Resnik Skin Institute is proud to announce that the first 2 Scenesse procedures in the United States were performed today at our clinic in Miami, Florida. Scenesse®, made by Clinuvel, Inc., is the revolutionary new treatment for Erythropoietic Protoporphyria (EPP), a disease that keeps its sufferers in the dark. Until now.
The FDA approved its use for EPP in October 2019. It stimulates the body’s color cells to make pigment in the skin, blocking the prolonged skin pain that patients experience with even the slightest exposure to sunlight. Some patients cannot even tolerate indoor lighting. It is placed under the skin using local anesthetic an in-office procedure. If you know someone who suffers from EPP or you have it yourself, please contact us for more information about Scenesse®. It is life-changing.